{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T02:26:55Z","timestamp":1790476015970,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jad.2023.10.034","type":"journal-article","created":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T05:38:36Z","timestamp":1696916316000},"page":"141-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Structural and functional brain imaging after treatment with selective-serotonin reuptake-inhibitors in obsessive-compulsive disorder: A mini review"],"prefix":"10.1016","volume":"345","author":[{"given":"L.","family":"Bracco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Dusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Moltrasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Brambilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Delvecchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2023.10.034_bb0005","series-title":"Depress. Anxiety","article-title":"Dissecting ocd circuits: from animal models to targeted treatments","volume":"Vol. 32, Issue 8","author":"Ahmari","year":"2015"},{"issue":"6137","key":"10.1016\/j.jad.2023.10.034_bb0010","doi-asserted-by":"crossref","DOI":"10.1126\/science.1234733","article-title":"Repeated cortico-striatal stimulation generates persistent OCD-like behavior","volume":"340","author":"Ahmari","year":"2013","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.jad.2023.10.034_bb0015","first-page":"58","article-title":"Effects of anti-obsessional treatment on pituitary volumes in obsessive-compulsive disorder","volume":"28","author":"Atmaca","year":"2016","journal-title":"Psychiatr. Danub."},{"issue":"2","key":"10.1016\/j.jad.2023.10.034_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/S0006-3223(98)00154-1","article-title":"Effect of long-term administration of antidepressant treatments on serotonin release in brain regions involved in obsessive-compulsive disorder","volume":"45","author":"Bergqvist","year":"1999","journal-title":"Biol. Psychiatry"},{"issue":"12","key":"10.1016\/j.jad.2023.10.034_bb0025","doi-asserted-by":"crossref","DOI":"10.1038\/npp.2009.77","article-title":"Anti-brain autoantibodies and altered excitatory neurotransmitters in obsessive-compulsive disorder","volume":"34","author":"Bhattacharyya","year":"2009","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.jad.2023.10.034_bb0030","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1176\/appi.neuropsych.15090213","article-title":"The effect of intravenous citalopram on the neural substrates of obsessive-compulsive disorder","volume":"28","author":"Bhikram","year":"2016","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"issue":"12","key":"10.1016\/j.jad.2023.10.034_bb0035","doi-asserted-by":"crossref","DOI":"10.1176\/appi.ajp.2008.08020320","article-title":"Meta-analysis of the symptom structure of obsessive-compulsive disorder","volume":"165","author":"Bloch","year":"2008","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2023.10.034_bb0040","article-title":"Structural neuroimaging biomarkers for obsessive-compulsive disorder in the ENIGMA-OCD consortium: medication matters. Translational","volume":"10","author":"Bruin","year":"2020","journal-title":"Psychiatry"},{"issue":"9","key":"10.1016\/j.jad.2023.10.034_bb0045","doi-asserted-by":"crossref","DOI":"10.1038\/sj.npp.1300733","article-title":"Glutamatergic dysfunction in OCD","volume":"30","author":"Chakrabarty","year":"2005","journal-title":"Neuropsychopharmacology"},{"issue":"11","key":"10.1016\/j.jad.2023.10.034_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184923","article-title":"The relation between statistical power and inference in fMRI","volume":"12","author":"Cremers","year":"2017","journal-title":"PLoS One"},{"issue":"Suppl 14","key":"10.1016\/j.jad.2023.10.034_bb3230","first-page":"11","article-title":"The role of dopamine in obsessive-compulsive disorder: preclinical and clinical evidence","volume":"65","author":"Denys","year":"2004","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2023.10.034_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035889","article-title":"Abnormalities of white matter microstructure in unmedicated obsessive-compulsive disorder and changes after medication","volume":"7","author":"Fan","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jad.2023.10.034_bb0060","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19r13085","article-title":"Women are at greater risk of OCD than men: a meta-analytic review of OCD prevalence worldwide","volume":"81","author":"Fawcett","year":"2020","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2023.10.034_bb0065","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1017\/S1461145704004675","article-title":"Evidence-based pharmacotherapy of obsessive-compulsive disorder","volume":"8","author":"Fineberg","year":"2005","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.jad.2023.10.034_bb0070","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.biopsych.2004.10.038","article-title":"Error-related hyperactivity of the anterior cingulate cortex in obsessive-compulsive disorder","volume":"57","author":"Fitzgerald","year":"2005","journal-title":"Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.jad.2023.10.034_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaac.2011.06.011","article-title":"Developmental alterations of frontal-striatal-thalamic connectivity in obsessive-compulsive disorder","volume":"50","author":"Fitzgerald","year":"2011","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"8 SUPPL","key":"10.1016\/j.jad.2023.10.034_bb0080","article-title":"Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive-compulsive disorder","volume":"51","author":"Goodman","year":"1990","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2023.10.034_bb0085","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/npp.2011.250","article-title":"Gray matter volumes in obsessive-compulsive disorder before and after fluoxetine or cognitive-behavior therapy: a randomized clinical trial","volume":"37","author":"Hoexter","year":"2012","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.jad.2023.10.034_bb0090","doi-asserted-by":"crossref","first-page":"333","DOI":"10.31887\/DCNS.2009.11.3\/jhunsberger","article-title":"The neurotrophic and neuroprotective effects of psychotropic agents","volume":"11","author":"Hunsberger","year":"2009","journal-title":"Dialogues Clin. Neurosci."},{"issue":"5","key":"10.1016\/j.jad.2023.10.034_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/0006-3223(90)90408-T","article-title":"Clomipramine in obsessive-compulsive disorder","volume":"28","author":"Katz","year":"1990","journal-title":"Biol. Psychiatry"},{"issue":"12","key":"10.1016\/j.jad.2023.10.034_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2019.04.022","article-title":"Mapping cortical and subcortical asymmetry in obsessive-compulsive disorder: findings from the ENIGMA consortium","volume":"87","author":"Kong","year":"2020","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2023.10.034_bb0110","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.neuroimage.2004.08.041","article-title":"Dysfunctional action monitoring hyperactivates frontal-striatal circuits in obsessive-compulsive disorder: an event-related fMRI study","volume":"24","author":"Maltby","year":"2005","journal-title":"NeuroImage"},{"issue":"3","key":"10.1016\/j.jad.2023.10.034_bb0115","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.neubiorev.2007.09.005","article-title":"Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited","volume":"32","author":"Menzies","year":"2008","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1","key":"10.1016\/j.jad.2023.10.034_bb0120","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.tics.2011.11.003","article-title":"Obsessive-compulsive disorder: beyond segregated cortico-striatal pathways","volume":"16","author":"Milad","year":"2012","journal-title":"Trends Cogn. Sci."},{"issue":"8","key":"10.1016\/j.jad.2023.10.034_bb0125","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.biopsych.2004.12.039","article-title":"Brain activation of patients with obsessive-compulsive disorder during neuropsychological and symptom provocation tasks before and after symptom improvement: a functional magnetic resonance imaging study","volume":"57","author":"Nakao","year":"2005","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2023.10.034_bb0130","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.pscychresns.2009.05.002","article-title":"A functional magnetic resonance imaging study of inhibitory control in obsessive-compulsive disorder","volume":"174","author":"Page","year":"2009","journal-title":"Psychiatry Res."},{"issue":"6","key":"10.1016\/j.jad.2023.10.034_bb0135","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nrn3746","article-title":"Obsessive-compulsive disorder: an integrative genetic and neurobiological perspective","volume":"15","author":"Pauls","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.jad.2023.10.034_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2008.04.233","article-title":"In vivo PET study of 5HT2A serotonin and D2 dopamine dysfunction in drug-naive obsessive-compulsive disorder","volume":"42","author":"Perani","year":"2008","journal-title":"NeuroImage"},{"issue":"2","key":"10.1016\/j.jad.2023.10.034_bb3235","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0006-3223(89)90022-X","article-title":"Animal models of compulsive behavior","volume":"26","author":"Pitman","year":"1989","journal-title":"Biol. Psych."},{"key":"10.1016\/j.jad.2023.10.034_bb0145","series-title":"Psychiatric Clinics of North America","article-title":"Pharmacological treatment of obsessive-compulsive disorder","volume":"Vol. 37, Issue 3","author":"Pittenger","year":"2014"},{"issue":"3","key":"10.1016\/j.jad.2023.10.034_bb0155","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.biopsych.2005.12.012","article-title":"Functional magnetic resonance imaging study of regional brain activation during implicit sequence learning in obsessive-compulsive disorder","volume":"61","author":"Rauch","year":"2007","journal-title":"Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.jad.2023.10.034_bb0160","doi-asserted-by":"crossref","DOI":"10.1097\/00004583-200009000-00008","article-title":"Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine","volume":"39","author":"Rosenberg","year":"2000","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"9","key":"10.1016\/j.jad.2023.10.034_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2005.05.007","article-title":"Reduced anterior cingulate glutamate in pediatric major depression: a magnetic resonance spectroscopy study","volume":"58","author":"Rosenberg","year":"2005","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2023.10.034_bb0170","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0193-953X(05)70181-7","article-title":"Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder","volume":"23","author":"Saxena","year":"2000","journal-title":"Psychiatr. Clin. N. Am."},{"issue":"2","key":"10.1016\/j.jad.2023.10.034_bb0175","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/scnp.2001.21833","article-title":"Brain-behavior relationships in obsessive-compulsive disorder","volume":"6","author":"Saxena","year":"2001","journal-title":"Semin. Clin. Neuropsychiatry"},{"issue":"8","key":"10.1016\/j.jad.2023.10.034_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/S2215-0366(16)30069-4","article-title":"Pharmacological and psychotherapeutic interventions for management of obsessive-compulsive disorder in adults: a systematic review and network meta-analysis","volume":"3","author":"Skapinakis","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jad.2023.10.034_bb3245","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.bbr.2019.03.009","article-title":"Repeated fluoxetine treatment induces long-lasting neurotrophic changes in the medial prefrontal cortex of adult rats","volume":"365","author":"Song","year":"2019","journal-title":"Behav. Brain Res."},{"issue":"7","key":"10.1016\/j.jad.2023.10.034_bb0185","doi-asserted-by":"crossref","DOI":"10.1007\/s00702-008-0045-4","article-title":"A 1H magnetic resonance spectroscopy study in adults with obsessive compulsive disorder: relationship between metabolite concentrations and symptom severity","volume":"115","author":"Starck","year":"2008","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.jad.2023.10.034_bb0190","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bbr.2016.07.004","article-title":"Cortico-striato-thalamo-cortical circuit abnormalities in obsessive-compulsive disorder: a voxel-based morphometric and fMRI study of the whole brain","volume":"313","author":"Tang","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.jad.2023.10.034_bb0195","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jad.2022.09.035","article-title":"White matter microstructural abnormalities and gray matter volume alterations in obsessive-compulsive disorder: a coordinate-based meta-analysis","volume":"320","author":"Tao","year":"2023","journal-title":"J. Affect. Disord."},{"issue":"7","key":"10.1016\/j.jad.2023.10.034_bb0200","doi-asserted-by":"crossref","DOI":"10.1038\/mp.2012.76","article-title":"Molecular genetics of obsessive-compulsive disorder: a comprehensive meta-analysis of genetic association studies","volume":"18","author":"Taylor","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2023.10.034_bb0205","series-title":"Current Opinion in Neurobiology","article-title":"Neurobiology of obsessive-compulsive disorder: insights into neural circuitry dysfunction through mouse genetics","volume":"Vol. 21, Issue 6","author":"Ting","year":"2011"},{"issue":"2","key":"10.1016\/j.jad.2023.10.034_bb3240","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0006-3223(01)01207-0","article-title":"Effect of nicotine on quinpirole-induced checking behavior in rats: implications for obsessive-compulsive disorder","volume":"51","author":"Tizabi","year":"2002","journal-title":"Biol. Psych."},{"issue":"1","key":"10.1016\/j.jad.2023.10.034_bb0210","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cogbrainres.2005.01.004","article-title":"Outcome representations, counterfactual comparisons and the human orbitofrontal cortex: implications for neuroimaging studies of decision-making","volume":"23","author":"Ursu","year":"2005","journal-title":"Brain Res. Cogn. Brain Res."},{"issue":"1","key":"10.1016\/j.jad.2023.10.034_bb0215","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pscychresns.2004.07.001","article-title":"A meta-analysis of functional neuroimaging in obsessive-compulsive disorder","volume":"132","author":"Whiteside","year":"2004","journal-title":"Psychiatry Res."},{"issue":"2","key":"10.1016\/j.jad.2023.10.034_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.pscychresns.2005.12.006","article-title":"A magnetic resonance spectroscopy investigation of obsessive-compulsive disorder and anxiety","volume":"146","author":"Whiteside","year":"2006","journal-title":"Psychiatry Res. Neuroimaging"},{"issue":"3","key":"10.1016\/j.jad.2023.10.034_bb0225","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1600-0447.2007.01046.x","article-title":"White matter abnormalities in drug-na\u00efve patients with obsessive-compulsive disorder: a diffusion tensor study before and after citalopram treatment","volume":"116","author":"Yoo","year":"2007","journal-title":"Acta Psychiatr. Scand."},{"issue":"6","key":"10.1016\/j.jad.2023.10.034_bb0230","doi-asserted-by":"crossref","DOI":"10.1080\/00048670802050546","article-title":"Anterior cingulate glutamate-glutamine levels predict symptom severity in women with obsessive-compulsive disorder","volume":"42","author":"Y\u00fccel","year":"2008","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.jad.2023.10.034_bb0235","article-title":"From the neuron doctrine to neural networks","volume":"Vol. 16, Issue 8","author":"Yuste","year":"2015","journal-title":"Nat. Rev. Neurosci."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032723012211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032723012211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T04:10:46Z","timestamp":1759032646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032723012211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":49,"alternative-id":["S0165032723012211"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2023.10.034","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural and functional brain imaging after treatment with selective-serotonin reuptake-inhibitors in obsessive-compulsive disorder: A mini review","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2023.10.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}